Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity.

Bioorg Med Chem Lett

Department of Medicinal Chemistry, Technology Enabled Synthesis Group, Merck & Co., PO Box 4, West Point, PA 19486, USA.

Published: January 2008

This letter describes the development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved aqueous solubility (approximately 18 mg/mL) that translates into enhanced cell activity and caspase-3 induction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.11.015DOI Listing

Publication Analysis

Top Keywords

development potent
8
potent allosteric
8
allosteric dual
8
dual akt1
8
akt1 akt2
8
akt2 inhibitors
8
inhibitors improved
8
cell activity
8
improved physical
4
physical properties
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!